Back to top

TransMedics Group (TMDX) Has a New Rating from Roth MKM

TransMedics Group received a Buy rating and a $155.00 price target from Roth MKM analyst today. The company’s shares closed yesterday at $114.29. I...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

TransMedics Group, Inc. (TMDX)